Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

October’s top news stories

UCB has signed a merger agreement to acquire Ra Pharmaceuticals for $48 per share, totalling $2.1bn in cash, and Novartis has allied with Microsoft to leverage the latter’s AI technology for the discovery, development and commercialisation of medicines. Pharmaceutical-technology.com wraps up key headlines from October 2019.

Download our 2019 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top